Patents by Inventor Christiane Fetzer

Christiane Fetzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Infectious CDNA clone of european PRRS virus and uses thereof
    Patent number: 9315781
    Abstract: The present invention belongs to the field of animal health and relates to a nucleic acid sequence which comprises the genome of an infectious genotype I (EU) PRRS virus clone useful for studying Porcine Reproductive and Respiratory Syndrome (PRRS), a viral disease affecting swine, and in the development of vaccines, therapeutics and diagnostics for the prophylaxis, treatment and diagnosis of PRRS.
    Type: Grant
    Filed: July 30, 2012
    Date of Patent: April 19, 2016
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Christiane Fetzer, Andreas Gallei
  • INFECTIOUS CDNA CLONE OF EUROPEAN PRRS VIRUS AND USES THEREOF
    Publication number: 20140314808
    Abstract: The present invention belongs to the field of animal health and relates to a nucleic acid sequence which comprises the genome of an infectious genotype I (EU) PRRS virus clone useful for studying Porcine Reproductive and Respiratory Syndrome (PRRS), a viral disease affecting swine, and in the development of vaccines, therapeutics and diagnostics for the prophylaxis, treatment and diagnosis of PRRS.
    Type: Application
    Filed: July 30, 2012
    Publication date: October 23, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GBMH
    Inventors: Christiane Fetzer, Andreas Gallie
  • Infectious bovine viral diarrhea virus
    Patent number: 8778355
    Abstract: The invention belongs to the field of animal health and in particular Bovine Viral Diarrhea Virus (BVDV). The invention provides infectious BVDV clones and methods to produce said BVDV clones. The invention further relates to methods of attenuating said clones, attenuated BVDV clones and vaccines comprising said attenuated clones.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: July 15, 2014
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Knut Elbers, Christiane Fetzer, Martina von Freyburg, Gregor Meyers
  • Vaccine comprising an attenuated pestivirus
    Patent number: 7572455
    Abstract: Attenuated pestiviruses, in particular attenuated BVDV, wherein at least one mutation is in the coding sequence for glycoprotein Erns and at least another mutation in the coding sequence for Npro which preferably leads to combined inactivation of the RNase activity residing in glycoprotein Erns in addition to the inactivation of the (hypothesized) immunomodulating activity residing in Npro. Methods for attenuating pestiviruses such as BVDV, nucleic acids encoding the pestiviruses, in particular BVDV, compositions and vaccines comprising the attenuated pestiviruses, in particular BVDV, of the invention.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: August 11, 2009
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Gregor Meyers, Andreas Ege, Christiane Fetzer, Martina von Freyburg
  • PRRS vaccines
    Patent number: 7368117
    Abstract: The present invention is related to improved modified live PRRS vaccines of European genotype and new PRRSV strains which can be used for the manufacture of such vaccines.
    Type: Grant
    Filed: January 13, 2006
    Date of Patent: May 6, 2008
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Christiane Fetzer, Stefan Pesch
  • PRRS Vaccines
    Publication number: 20060286123
    Abstract: The present invention is related to improved modified live PRRS vaccines of European genotype and new PRRSV strains which can be used for the manufacture of such vaccines.
    Type: Application
    Filed: January 13, 2006
    Publication date: December 21, 2006
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Christiane FETZER, Stefan Pesch
  • Vaccine comprising an attenuated pestivirus
    Publication number: 20050287171
    Abstract: Attenuated pestiviruses, in particular attenuated BVDV, wherein at least one mutation is in the coding sequence for glycoprotein Erns and at least another mutation in the coding sequence for Npro which preferably leads to combined inactivation of the RNase activity residing in glycoprotein Erns in addition to the inactivation of the (hypothesized) immunomodulating activity residing in Npro. Methods for attenuating pestiviruses such as BVDV, nucleic acids encoding the pestiviruses, in particular BVDV, compositions and vaccines comprising the attenuated pestiviruses, in particular BVDV, of the invention.
    Type: Application
    Filed: May 19, 2005
    Publication date: December 29, 2005
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Gregor Meyers, Andreas Ege, Christiane Fetzer, Martina von Freyburg